cilostazol has been researched along with pyruvic acid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, HN; Kim, TY; Koh, JY; Yoon, YH | 1 |
1 other study(ies) available for cilostazol and pyruvic acid
Article | Year |
---|---|
Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death.
Topics: Animals; Antigens; Cell Death; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Cilostazol; Cyclic AMP; Ethylenediamines; Fibrinolytic Agents; L-Lactate Dehydrogenase; Nerve Tissue Proteins; Pericytes; Proteoglycans; Pyruvic Acid; Rats; Reactive Oxygen Species; Receptor, Platelet-Derived Growth Factor alpha; Tetrazoles; Tissue Plasminogen Activator; Zinc | 2015 |